Charles River Laboratories Inte vs Thermo Fisher Scientific Inc
A head-to-head of Charles River Laboratories Inte (CRL) and Thermo Fisher Scientific Inc (TMO) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | CRL | TMO |
|---|---|---|
| Market Cap | $10.81B | $197.88B |
| P/E (TTM) | — | 29.27 |
| Forward P/E | 12.37 | 19.34 |
| P/S | 1.82 | 3.69 |
| P/B | 3.70 | 4.56 |
| EV/EBITDA | 11.45 | 18.29 |
| Dividend Yield | — | 0.27% |
| Profit Margin | -4.59% | 15.15% |
| Gross Margin | 32.96% | 40.93% |
| Operating Margin | 9.99% | 18.20% |
| Revenue Growth (YoY) | +1.19% | +6.18% |
| FCF Yield | — | 4.05% |
| Debt / Equity | 89.12 | 82.90 |
| Current Ratio | 1.36 | 1.53 |
Which is better: Charles River Laboratories Inte or Thermo Fisher Scientific Inc?
- ✓Larger by market cap: Thermo Fisher Scientific Inc
- ✓More profitable (net margin): Thermo Fisher Scientific Inc
- ✓Faster revenue growth: Thermo Fisher Scientific Inc
Across 10 available metrics, Thermo Fisher Scientific Inc leads 6–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.